ME03337B - Industrijski postupak za sintezu ulipristal acetata i njegovog 4'-acetil analoga - Google Patents

Industrijski postupak za sintezu ulipristal acetata i njegovog 4'-acetil analoga

Info

Publication number
ME03337B
ME03337B MEP-2019-56A MEP201956A ME03337B ME 03337 B ME03337 B ME 03337B ME P201956 A MEP201956 A ME P201956A ME 03337 B ME03337 B ME 03337B
Authority
ME
Montenegro
Prior art keywords
synthesis
industrial process
ulipristal acetate
analogue
acetyl
Prior art date
Application number
MEP-2019-56A
Other languages
German (de)
English (en)
French (fr)
Inventor
Sándor Mahó
Csaba Sánta
János Csörgei
János Horváth
Antal Aranyi
Zoltán Béni
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of ME03337B publication Critical patent/ME03337B/me

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
MEP-2019-56A 2013-10-01 2014-10-01 Industrijski postupak za sintezu ulipristal acetata i njegovog 4'-acetil analoga ME03337B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU1300566A HU230319B1 (hu) 2013-10-01 2013-10-01 Ipari eljárás szteroid hatóanyagok előállítására
EP14790731.5A EP3052513B1 (en) 2013-10-01 2014-10-01 Industrial process for the synthesis of ulipristal acetate and its 4'-acetyl analogue
PCT/IB2014/064979 WO2015049637A1 (en) 2013-10-01 2014-10-01 Industrial process for the synthesis of ulipristal acetate and its 4'-acetyl analogue

Publications (1)

Publication Number Publication Date
ME03337B true ME03337B (me) 2019-10-20

Family

ID=89991273

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2019-56A ME03337B (me) 2013-10-01 2014-10-01 Industrijski postupak za sintezu ulipristal acetata i njegovog 4'-acetil analoga

Country Status (32)

Country Link
US (1) US9676814B2 (me)
EP (1) EP3052513B1 (me)
JP (1) JP6796366B2 (me)
KR (1) KR20160062046A (me)
CN (1) CN105593236B (me)
AR (1) AR097878A1 (me)
AU (1) AU2014330860B2 (me)
BR (1) BR112016006979B1 (me)
CA (1) CA2924553C (me)
CY (1) CY1121286T1 (me)
DK (1) DK3052513T3 (me)
EA (1) EA030905B1 (me)
ES (1) ES2713325T3 (me)
GE (1) GEP20186827B (me)
HR (1) HRP20190414T1 (me)
HU (2) HU230319B1 (me)
IL (1) IL244501A0 (me)
LT (1) LT3052513T (me)
ME (1) ME03337B (me)
MX (1) MX355222B (me)
MY (1) MY176613A (me)
PL (1) PL3052513T3 (me)
PT (1) PT3052513T (me)
RS (1) RS58252B1 (me)
SG (1) SG11201601683SA (me)
SI (1) SI3052513T1 (me)
SM (1) SMT201900125T1 (me)
TR (1) TR201901381T4 (me)
UA (1) UA118269C2 (me)
UY (1) UY35766A (me)
WO (1) WO2015049637A1 (me)
ZA (1) ZA201601589B (me)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230381B1 (hu) * 2014-02-17 2016-03-29 Richter Gedeon Nyrt Ipari eljárás szteroid intermedier előállítására
CN105237607B (zh) * 2015-10-29 2018-10-02 国家卫生计生委科学技术研究所 醋酸乌利司他晶k型物质及制备方法和其组合物与用途
CN112461957B (zh) * 2020-11-12 2022-02-22 湖南新合新生物医药有限公司 一种检测醋酸乌利司他中间体ii中杂质含量的方法
CN112578037A (zh) * 2020-11-12 2021-03-30 湖南新合新生物医药有限公司 一种检测醋酸乌利司他中间体ⅰ中乌双缩酮含量的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954490A (en) 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
US5929262A (en) 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
US6861415B2 (en) * 1996-05-01 2005-03-01 The United States Of America As Represented By The Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
US6020328A (en) 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
EP2033965A3 (en) 2000-03-17 2012-09-19 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
CA2516319C (en) * 2003-02-28 2012-09-18 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Method for preparing 17.alpha.-acetoxy-11.beta.-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
HU227112B1 (hu) * 2006-06-14 2010-07-28 Richter Gedeon Nyrt Ipari eljárás 17-alfa-acetoxi-11-béta-[4-(N,N-dimetil-amino)-fenil]-19-norpregna-4,9-dién-3,20-dion elõállítására és új intermedierek az eljáráshoz
HU228636B1 (en) * 2007-06-27 2013-04-29 Richter Gedeon Nyrt Industrial method for the synthesis of 17-acetoxy-11betha-4[-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process
CN102477060B (zh) * 2010-11-22 2014-08-13 华润紫竹药业有限公司 甾体化合物及其制备方法和用途
CN102516345B (zh) * 2011-11-01 2014-11-26 上海优拓医药科技有限公司 醋酸乌利司他及其关键中间体的制备方法
CN103601785A (zh) * 2013-11-25 2014-02-26 四川大学 一种醋酸优力斯特新的合成方法

Also Published As

Publication number Publication date
PL3052513T3 (pl) 2019-05-31
CN105593236A (zh) 2016-05-18
PT3052513T (pt) 2019-03-01
KR20160062046A (ko) 2016-06-01
DK3052513T3 (en) 2019-03-25
ES2713325T3 (es) 2019-05-21
HK1223105A1 (en) 2017-07-21
JP2016533347A (ja) 2016-10-27
HUP1300566A2 (en) 2015-04-28
AU2014330860B2 (en) 2018-10-18
TR201901381T4 (tr) 2019-02-21
EA201690467A1 (ru) 2016-07-29
BR112016006979A2 (pt) 2017-08-01
US20160311849A1 (en) 2016-10-27
EP3052513B1 (en) 2018-12-05
SMT201900125T1 (it) 2019-05-10
AR097878A1 (es) 2016-04-20
UY35766A (es) 2015-04-30
MY176613A (en) 2020-08-18
CA2924553A1 (en) 2015-04-09
WO2015049637A1 (en) 2015-04-09
BR112016006979B1 (pt) 2022-05-03
IL244501A0 (en) 2016-04-21
GEP20186827B (en) 2018-02-26
NZ717638A (en) 2021-05-28
ZA201601589B (en) 2017-07-26
CA2924553C (en) 2021-10-19
MX355222B (es) 2018-04-10
RS58252B1 (sr) 2019-03-29
JP6796366B2 (ja) 2020-12-09
EP3052513A1 (en) 2016-08-10
EA030905B1 (ru) 2018-10-31
LT3052513T (lt) 2019-02-25
CN105593236B (zh) 2017-11-28
SG11201601683SA (en) 2016-04-28
HUE043002T2 (hu) 2019-07-29
SI3052513T1 (sl) 2019-03-29
CY1121286T1 (el) 2020-05-29
HRP20190414T1 (hr) 2019-04-19
US9676814B2 (en) 2017-06-13
UA118269C2 (uk) 2018-12-26
AU2014330860A1 (en) 2016-03-24
MX2016004263A (es) 2016-10-12
HU230319B1 (hu) 2016-01-28

Similar Documents

Publication Publication Date Title
EP3392266A4 (en) LINACLOTIDSYNTHESEVERFAHREN
EP2882702A4 (en) SYNTHETIC GIPS FERTILIZER AND MANUFACTURING PROCESS
MA48723A (fr) Procédé de production d'anticorps multispécifiques
EP3632541A4 (en) FUNCTIONAL STRUCTURE AND MANUFACTURING PROCESS FOR FUNCTIONAL STRUCTURE
EP3632549A4 (en) FUNCTIONAL STRUCTURE AND MANUFACTURING PROCESS FOR FUNCTIONAL STRUCTURE
EP2980049A4 (en) CERAMIC WAVE STRUCTURE AND MANUFACTURING METHOD THEREFOR
EP2937143A4 (en) CERAMIC WAVE STRUCTURE AND METHOD FOR THE PRODUCTION THEREOF
EP2835369A4 (en) CRYSTALLINE FORM OF CABAZITAXEL AND MANUFACTURING METHOD THEREFOR
EP3632548A4 (en) FUNCTIONAL STRUCTURE AND MANUFACTURING PROCESS FOR FUNCTIONAL STRUCTURE
EP2951141A4 (en) PROCESS FOR THE PRODUCTION OF POLYOLES
EP3385359A4 (en) DOCOSAHEXAIC ACID-CONTAINING OIL AND METHOD FOR THE PRODUCTION THEREOF
EP2951158A4 (en) PROCESS FOR THE PREPARATION OF IVACAFTOR AND SOLVATES THEREOF
EP3360901A4 (en) CELLULOSE ACETATE AND METHOD AND DEVICE FOR PREPARING CELLULOSE ACETATE
EP2957543A4 (en) PROCESS FOR THE PREPARATION OF TRICHLOROSILANE
EP2859943A4 (en) GOLDCLUSTERKATALYSATOR AND METHOD FOR THE PRODUCTION THEREOF
EP3690040A4 (en) PROTEIN PRODUCTION PROCEDURES AND DISACCHARID PRODUCTION PROCESSES
EP2982843A4 (en) SHIELDING AND PROCESS FOR PREPARING A SHIELD
ME03337B (me) Industrijski postupak za sintezu ulipristal acetata i njegovog 4'-acetil analoga
EP3045038A4 (en) MATERIAL FOR THE TREATMENT OF EXCREMENTS AND METHOD FOR THE PRODUCTION THEREOF
EP2945946A4 (en) PROCESS FOR PREPARING AND CLEANING APIXABAN
EP3412318A4 (en) DEODORANT PRODUCTION PROCESS AND DEODORANT
EP2841447A4 (en) A NEW COMPOSITION FOR EXTRACORPORAL REDUCTION OF BETA AMYLOIDS AND METHOD FOR THE PRODUCTION THEREOF
EP3305687A4 (en) MATERIAL FOR THE TREATMENT OF EXCREMENTS AND METHOD FOR THE PRODUCTION THEREOF
EP3685845A4 (en) COMPOSITION AND MANUFACTURING PROCESS FOR IT
EP3915975C0 (en) Method for producing 5-hydroxypiperidine-2-carboxylic acid